Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 3Phase NA 2Phase 4 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thromboembolism 2Venous Thrombosis 1Thrombosis 1Sarcoma 1Pulmonary Embolism 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Fractures, Spontaneous 1Femoral Fractures 1Bone Neoplasms 1

Interventions

Rivaroxaban 3apixaban 2Heparin, Low-Molecular-Weight 2Fondaparinux 2Enoxaparin 2Dalteparin 2enoxaparin sodium 1edoxaban 1Warfarin 1Tinzaparin 1Nadroparin 1Long-Term Synaptic Depression 1Hematologic Tests 1Educational Status 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Venous Thromboembolism × Dalteparin × Clear all
NCT06583330 2024-09-04

A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery

Beijing Friendship Hospital

Phase NA Not yet recruiting
1,448 enrolled
Classical hematology

Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡